Early abortion update and implications for midwifery practice

Journal of Nurse-Midwifery

Volumn 43, Issue 6, 1998, Pages 492-501

  Narrigan, Deborah ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; DRUG; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE;

ABORTION, DRUG INDUCED; BIOLOGY; DEVELOPED COUNTRY; ECONOMICS; ENDOCRINE SYSTEM; FAMILY PLANNING; FEMALE; FERTILITY CONTROL, POSTCONCEPTION; FIRST TRIMESTER PREGNANCY; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; INDUCED ABORTION; LITERATURE REVIEW; METHODOLOGY; NORTH AMERICA; NORTHERN AMERICA; NURSE MIDWIFE; NURSE-MIDWIVES; PHYSIOLOGY; PREGNANCY; REVIEW; SUCTION; TREATMENT; UNITED STATES; VACUUM; VACUUM ASPIRATION; WESTERN HEMISPHERE;

ABORTIFACIENT AGENTS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; AMERICAS; BIOLOGY; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; DRUGS; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; HEALTH; HEALTH PERSONNEL; LITERATURE REVIEW; METHOTREXATE; MISOPROSTOL; NORTH AMERICA; NORTHERN AMERICA; NURSE-MIDWIVES; PHYSIOLOGY; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; TREATMENT; UNITED STATES; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS; ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; FEMALE; HUMANS; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; NURSE MIDWIVES; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SUCTION; UNITED STATES; VACUUM;

EID: 0032201349     PISSN: 00912182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-2182(98)00057-3     Document Type: Article

References (50)

1. Mycek M, Harvey R, Champe P. Lippincott's illustrated reviews: pharmacology. Philadelphia: Lippincott-Raven, 1997.
2. American Hospital Formulary Service. Drug information 1997. Bethesda (MD): American Association of Health Systems Pharmaceuticals, Inc., 1997.
3. Methotrexate and misoprostol for abortion. Med Lett Drugs Ther 1996;38:39-40.
4. Stovall T, Mccord M. Early pregnancy loss and ectopic preg-nancy. In: Berek J. Novack's gynecology. 12th ed. Baltimore: Williams & Wilkins, 1996.
5. Donnenfeld A, Pastuszak A, Noah J, Schick B, Rose N, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994;49:79-81.
6. Crenin M, Vittinghoff E, Galbraith B, Klaisle C. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. Obstet Gynecol 1995;173:1578-84.
7. Carbonell J, Varela L, Velasco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997; 55:165-8.
8. Hadley J. Abortion between freedom and necessity. London: Virago Press, 1996.
9. Castilla E, Orioli I. Teratogenicity of misoprostol: data from the Latin-American collaborative study of congenital malformations (ECLAMC). Am J Med Genet 1994;51:161-2.
10. Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu E-E, Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. N Engl J Med 1990;322:645-8.
11. Creinin M, Darney P. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339-48.
12. Creinin M, Vittinghoff E. Methotrexate and misoprostol vs. misoprostol alone for early abortion: a randomized controlled trial. JAMA 1994;272:1190-5.
13. Schaff E, Eisinger S, Franks P, Kim S. Methotrexate and misoprostol for early abortion. Fam Med 1996-28:198-203.
14. Weibe E. Abortion induced with methotrexate and misoprostol. Can Med Assoc J 1996; 154:165-70.
15. Creinin M. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996;54:15-8.
16. Grimes D. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997;89:790-6.
17. Spitz M, Baron W, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-7.
18. Schaff E, Stadalius L, Eisinger S, Franks P. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Prac 1997;44:353-60.
19. Koonin L, Smith J, Ramick N, Strauss L, Hopkins F. Abortion surveillance-United States, 1993 and 1994. MMWR 1997;46:37-97.
20. Gold M, Luks D, Anderson M. Medical options for early pregnancy termination. Am Fam Physician 1997;56:533-8.
21. Bachelot A, Cludy L, Spira A. Conditions for choosing between drug-induced and surgical abortions. Contraception 1992;45:547-59.
22. Thong K, Dewar M, Baird D. What do women want during medical abortion? Contraception 1992;46:435-42.
23. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Persp 1995;271:42-8.
24. Henshaw R, Naji I, Russell A, Templeton A. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ 1993;307:714-7.
25. Henshaw R, Naji A, Russell I, Templeton A. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration: a patient-centered, partially randomized prospective study. Acta Obstet Gynecol Scand 1994;73: 812-8.
26. Howie F, Henshaw R, Naji S, Russell I, Templeton A. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997; 104:829-33.
27. Creinin M, Park M. Acceptability of medical abortion with methotrexate and misoprostol. Contraception 1995;52:41-4.
28. Weibe E. Choosing between surgical abortions and medical abortions induced with methotrexate and misoprostol. Contraception 1997;55:67-71.
29. Castle M, Harvey M, Beckman L, Coeytaux F, Garrity J. Listening and learning from women about mifepristone: implications for counseling and health education. Womens Health 1995;3:130-8.
30. Centers for Disease Control and Prevention. Abortion surveillance: preliminary analysis - United States, 1995. MMWR 1997;46:1133-7.
31. Gober P. The role of access in explaining state abortion rates. Soc Sci Med 1997;44:1003-16.
32. Henshaw S, Van Vort J. Abortion services in the United States, 1991 and 1992. Fam Plann Persp 1994;26:100-6.
33. Rosenblatt R, Mattis R, Hart L. Abortions in rural Idaho: physicians' attitudes and practice. Am J Public Health 1995;85:1423-5.
34. Ferris L, Basinski A. Medical abortion: what does the research tell us? Can Med Assoc J 1996;154:185-7.
35. Klitsch M. RU 486: the science and the politics. New York: The Alan Guttmacher Institute, 1989.
36. Edwards J, Carson SA. New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation. Am J Obstet Gynecol 1997;176:1101-6.
37. Chalker R, Downer C. A woman's book of choices: abortion, menstrual extraction and RU 486. San Francisco: Medea Books, 1992.
38. Lukman H, Pogharian D. Management of incomplete abortion with manual vacuum aspiration in comparison to sharp metallic curette in an Ethiopian setting. E African Med J 1996;73:598-603.
39. Otsea K, Baird T, Billings D, Taylor J. Midwives deliver post-abortion care services in Ghana. Dialogue IPAS 1997; 1:1-2.
40. McKee K, Adams E. Nurse-midwives' attitudes toward abortion performance and related procedures. J Nurse Midwifery 1994;39: 300-11.
41. American College of Obstetricians and Gynecologists. Statement on providers of abortion services. Washington (DC): ACOG, 1994.
42. Who will provide abortions? Ensuring the availability of qualified practitioners. Washington (DC): National Abortion Federation, 1990.
43. Vermont physician assistants perform abortions, train residents. Fam Plann Persp 1992;24:225.
44. Freedman M, Jillson D, Coffin R, Novick L. Comparison of complication rates in first trimester abortions performed by physician assistants and physicians. Am J Public Health 1996;76:550-4.
45. Grimes D. Clinicians who provide abortions: the thinning ranks. Obstet Gynecol 1992;80:719-23.
46. Joffe C. Doctors of conscience. Boston: Beacon Press, 1995.
47. Midwives for Choice. Abortion and midlevel providers: what is your legal status? Choice 1997; #4, 2 unnumbered pages.
48. Foods Drugs and Cosmetics Section 53-10-104 (c) (3). Nashville: Tennessee Code, Annotated: 196.
49. National Abortion Federation. Strategies for expanding abortion access: the role of physician assistants, nurse practitioners, and nurse-midwives in providing abortions. Washington (DC): National Abortion Federation, 1997.
50. Mackenzie SJ, Yeo S. Pregnancy interruption using mifepristone (RU 486): a new choice for women in the USA. J Nurse Midwifery 1997;42:86-90.